Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
94%
Neoplasm
90%
Cancer Chemotherapy
90%
Lung Cancer
76%
Cisplatin
70%
Non Small Cell Lung Cancer
59%
Lung Adenocarcinoma
59%
STAT3 Protein
59%
Breast Cancer
59%
Drug Resistance
59%
Chemotherapy
53%
Carboplatin
46%
Chelating Agent
46%
Combination Therapy
44%
Life Expectancy
42%
Ovary Cancer
39%
Drug Transport
39%
Chemoradiation Therapy
39%
Malignant Pleura Effusion
39%
Carcinoma
39%
Diseases
32%
Overall Survival
31%
Survival Rate
29%
Epidermal Growth Factor Receptor
29%
Interleukin 6
27%
Clinical Study
24%
Trientine
23%
Uterine Cervix Cancer
19%
Cyclooxygenase 2
19%
Gemcitabine
19%
Paclitaxel
19%
NK T Cell Lymphoma
19%
Tumor Necrosis Factor
19%
Liver Cell Carcinoma
19%
Epstein-Barr Virus
19%
Hypothyroidism
19%
High Dose Chemotherapy
19%
Estrogen Receptor
19%
Ceramide Glucosyltransferase
19%
Metastasis Free Survival
19%
Remission
19%
Hypoxia Inducible Factor 1
19%
Vinorelbine
19%
Nasopharynx Cancer
19%
Inducible Nitric Oxide Synthase
19%
Kwashiorkor
19%
Uncoupling Protein
19%
Uncoupling Protein 2
19%
Phase II Trials
19%
Alloy Nanoparticle
19%
Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
80%
Overall Survival
63%
Breast Cancer
59%
Metastatic Carcinoma
46%
Non Small Cell Lung Cancer
41%
Diseases
40%
Malignant Pleural Effusion
39%
STAT3 Protein
39%
Clinical Significance
39%
Rib
39%
Malignant Neoplasm
38%
Oropharynx Squamous Cell Carcinoma
35%
Cancer Treatment
35%
Disease Free Survival
33%
Uterine Cervix Carcinoma
31%
Lifespan
31%
Cancer
31%
Progression Free Survival
30%
Quality Adjusted Life Year
29%
Prognostic Factor
28%
Chemoradiotherapy
27%
Cancer Registry
27%
Colorectal Carcinoma
24%
Squamous Cell Carcinoma
24%
Cancer Therapy
23%
Treatment Response
23%
Life Expectancy
23%
Multivariate Analysis
22%
Oropharynx Carcinoma
22%
Treatment Effect
21%
Lung Cancer
19%
Terminal Illness
19%
Sinus Cancer
19%
Combined Therapy
19%
Ethmoid Sinus
19%
Homeostasis and Regulation
19%
Lung Adenocarcinoma
19%
Cervical Cancer
19%
Cost-Effectiveness Analysis
19%
Cardiovascular Disease
19%
Health Care Cost
19%
Bladder Cancer
19%
Starvation Therapy
19%
Cauda equina
19%
Adjuvant Radiotherapy
19%
Radiomics
19%
Stoma
19%
Total Mesorectal Excision
19%
Cardiology
19%
Keyphrases
Copper Transporter
39%
Malignant Pleural Effusion
39%
High Affinity
39%
CTR1
32%
Interleukin-6
29%
Prognostic Value
24%
Platinum Drug Resistance
23%
Adenocarcinoma Cells
23%
Cell Lung Cancer
23%
Cisplatin
23%
Human Copper Transporter 1
22%
Stage III Non-small Cell Lung Cancer
22%
Copper Homeostasis
21%
Postmastectomy
19%
Clinical Electron Beam
19%
Apoptotic Potential
19%
Taiwan
19%
Ethmoid Sinus Cancer
19%
Lung Adenocarcinoma Cells
19%
Ampullary
19%
Lung Adenocarcinoma
19%
Promoter Genes
19%
Signal Transducer and Activator of Transcription 3
19%
Virtual Wedge
19%
Cancer Treatment
19%
Dual Phase
19%
Cost-effectiveness
19%
Biliary Tract Carcinoma
19%
RTK Signaling
19%
Starvation Response
19%
Coronary Artery Calcium
19%
National Database Analysis
19%
Phospho-flow Cytometry
19%
Glutamine Starvation
19%
Platinum-based Antitumor Drugs
19%
Single Surgeon Experience
19%
Platinum-based Chemotherapy
19%
Chemoradiation
19%
DEC1
19%
Synthetic Lethality
19%
Cisplatin Cytotoxicity
19%
Neurophysiological Test
19%
Transanal Total Mesorectal Excision (taTME)
19%
FasL
19%
Neoadjuvant Chemoradiotherapy (nCRT)
19%
Cauda Equina
19%
Defunctioning Stoma
19%
Radiation-induced Heart Disease
19%
Therapeutic Radiology
19%
Epidermal Growth Factor Receptor Family
19%